Insider Trading
Filed: 2026-05-13
Key Insights
- Adam Derechin, Chief Operating Officer and EVP, acquired 500 shares of CNS common stock on 05/11/2026 at $0 consideration, indicating a grant or bonus rather than a market purchase.
- The transaction increased Derechin's beneficial ownership to 535,571 shares, demonstrating significant long-term stake alignment with company performance.
- The $0 price and transaction code 'G' indicate this was likely a restricted stock grant or equity compensation, a standard executive incentive arrangement rather than open market activity.
- No derivative securities transactions were reported, suggesting the executive's compensation structure relies primarily on direct equity ownership rather than options or other derivatives.